Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Suspended × Recurrence × Clear all

Phase

Phase 1/2 2 Phase NA 1 Phase 2 1 Phase 1 1

Status

Completed 250 Terminated 118 Recruiting 108 Unknown 65 Active not recruiting 44 Withdrawn 22 Not yet recruiting 22 Enrolling by invitation 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 11 Leukemia, Myeloid, Acute 11 Neoplasm Metastasis 8 Prostatic Neoplasms 6 Ovarian Neoplasms 6 Melanoma 6 Breast Neoplasms 6 Myelodysplastic Syndromes 5 Glioma 5 Triple Negative Breast Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Lung Neoplasms 4 Hematologic Neoplasms 4 Glioblastoma 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Lymphoma 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Lymphoma, B-Cell 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2

Interventions

zanubrutinib 1 tazemetostat 1 obinutuzumab 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06824701 2026-04-06

TARZAN

University of Utah

Phase 1 Suspended

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡